Biofil Chemicals

{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "37.76",
    "chg": 1.56,
    "chgp": "4.31%",
    "dir": 1,
    "prev_price": "36.20",
    "mcapval": "62.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE829A01014",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "2.02 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3828888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3828888.png",
        "date": "2026-02-09 15:00:09",
        "description": "Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 9 Feb 2026, propelled by robust buying interest and a near 10% intraday gain. The stock’s performance outpaced its sector and benchmark indices, reflecting renewed investor confidence despite a recent downtrend."
      },
      {
        "title": "Biofil Chemicals Surges 25.48% Amid Volatile Week Marked by Circuit Hits",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-surges-2548-amid-volatile-week-marked-by-circuit-hits-3826739",
        "imagepath": "",
        "date": "2026-02-07 17:19:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Upper circuit hit at ₹42.13 (+19.99%) amid robust buying</p>\n                    <p><strong>3 Feb:</strong> Another upper circuit at ₹46.02 (+9.99%) with strong volume</p>\n                    <p><strong>4 Feb:</strong> Sharp reversal to lower circuit at ₹42.51 (-8.26%)</p>\n                    <p><strong>4 Feb:</strong> Valuation upgrade to attractive status announced</p>\n                    <p><strong>5 Feb:</strong> Further plunge to lower circuit at ₹37.54 (-10.00%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.28.85</div></div>\n     ..."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-3824038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_mojoScore_3824038.png",
        "date": "2026-02-06 10:10:50",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biofil-chemicals-pharmaceuticals-ltd-fallingrising-3823382",
        "imagepath": "",
        "date": "2026-02-06 00:55:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Volatility</strong></p>\n<p>The stock has experienced significant turbulence over the past two days, with a cumulative loss of 18.43%. On 05-Feb, it touched an intraday low of ₹37.26, marking a near 10% decline within the session. The trading range was notably wide at ₹3.74, and the weighted average price indicated that most volume was transacted near the lower end of this range. This heightened volatility, calculated at 6.97% intraday, suggests increased selling pressure and uncertainty among investors.</p>\n<p>Despite the recent fall, the stock price remains above its 5-day, 20-day, and 50-day moving averages, though it is still below the 100-day and 200-day averages. This technical positioning indicates some short-term resilience but also highlights longer-term dow..."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3822496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_lower_circuit_3822496.png",
        "date": "2026-02-05 12:00:08",
        "description": "Shares of Biofil Chemicals & Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged sharply to hit the lower circuit limit on 5 Feb 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹37.54, down 10.0% on the day, marking its maximum permissible daily loss and underperforming both its sector and the broader market indices."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3820139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_lower_circuit_3820139.png",
        "date": "2026-02-04 10:00:16",
        "description": "Shares of Biofil Chemicals & Pharmaceuticals Ltd plunged sharply on 4 Feb 2026, hitting the lower circuit limit of 8.26% amid intense selling pressure. The stock underperformed its sector and broader market indices, reflecting mounting investor concerns and a sudden reversal after a brief rally."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shift Signals Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-valuation-shift-signals-renewed-price-attractiveness-3819499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_valuationdot_3819499.png",
        "date": "2026-02-04 08:00:45",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a positive change in price attractiveness despite a complex performance backdrop. This article analyses the recent valuation changes, compares them with industry peers, and examines the implications for investors amid the company’s mixed return profile."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Surges to Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3818123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3818123.png",
        "date": "2026-02-03 10:03:03",
        "description": "Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 3 February 2026, propelled by intense buying interest and a significant price rally. The stock closed with a maximum daily gain of 9.99%, reflecting strong investor confidence despite its current sell rating, underscoring a notable market event in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Surges 20% to Hit Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-20-to-hit-upper-circuit-amid-robust-buying-pressure-3816402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3816402.png",
        "date": "2026-02-02 11:00:11",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd witnessed a remarkable surge on 2 Feb 2026, hitting its upper circuit limit with a 19.99% gain to close at ₹42.13. The stock demonstrated strong buying momentum, outpacing its sector and broader market indices, driven by heightened investor interest and significant unfilled demand."
      }
    ],
    "total": 161,
    "sid": "386748",
    "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "caption": "Clarification On Price Movement",
      "datetime": "03-Feb-2026",
      "details": "Clarification on Price Movement",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Biofil Chemicals & Pharmaceuticals Ltd",
      "datetime": "03-Feb-2026",
      "details": "The Exchange has sought clarification from Biofil Chemicals & Pharmaceuticals Ltd on February 3 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 07/2025-26) Of The Company Scheduled To Be Held On Friday 13Th February 2026 .",
      "datetime": "03-Feb-2026",
      "details": "Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve 1. the Un-Audited Financial Results of the Company for the Quarter and Nine Month ended on 31st December 2025 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biofil Chemicals & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-09 15:00:09

Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 9 Feb 2026, propelled by robust buying interest and a near 10% intraday gain. The stock’s performance outpaced its sector and benchmark indices, reflecting renewed investor confidence despite a recent downtrend.

Read full news article

Biofil Chemicals Surges 25.48% Amid Volatile Week Marked by Circuit Hits

2026-02-07 17:19:31

Key Events This Week

2 Feb: Upper circuit hit at ₹42.13 (+19.99%) amid robust buying

3 Feb: Another upper circuit at ₹46.02 (+9.99%) with strong volume

4 Feb: Sharp reversal to lower circuit at ₹42.51 (-8.26%)

4 Feb: Valuation upgrade to attractive status announced

5 Feb: Further plunge to lower circuit at ₹37.54 (-10.00%)

Week Open

Rs.28.85

...

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-02-06 10:10:50

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?

2026-02-06 00:55:07

Recent Price Movement and Volatility

The stock has experienced significant turbulence over the past two days, with a cumulative loss of 18.43%. On 05-Feb, it touched an intraday low of ₹37.26, marking a near 10% decline within the session. The trading range was notably wide at ₹3.74, and the weighted average price indicated that most volume was transacted near the lower end of this range. This heightened volatility, calculated at 6.97% intraday, suggests increased selling pressure and uncertainty among investors.

Despite the recent fall, the stock price remains above its 5-day, 20-day, and 50-day moving averages, though it is still below the 100-day and 200-day averages. This technical positioning indicates some short-term resilience but also highlights longer-term dow...

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-05 12:00:08

Shares of Biofil Chemicals & Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged sharply to hit the lower circuit limit on 5 Feb 2026, reflecting intense selling pressure and panic among investors. The stock closed at ₹37.54, down 10.0% on the day, marking its maximum permissible daily loss and underperforming both its sector and the broader market indices.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-04 10:00:16

Shares of Biofil Chemicals & Pharmaceuticals Ltd plunged sharply on 4 Feb 2026, hitting the lower circuit limit of 8.26% amid intense selling pressure. The stock underperformed its sector and broader market indices, reflecting mounting investor concerns and a sudden reversal after a brief rally.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd: Valuation Shift Signals Renewed Price Attractiveness

2026-02-04 08:00:45

Biofil Chemicals & Pharmaceuticals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a positive change in price attractiveness despite a complex performance backdrop. This article analyses the recent valuation changes, compares them with industry peers, and examines the implications for investors amid the company’s mixed return profile.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-02-03 10:03:03

Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 3 February 2026, propelled by intense buying interest and a significant price rally. The stock closed with a maximum daily gain of 9.99%, reflecting strong investor confidence despite its current sell rating, underscoring a notable market event in the Pharmaceuticals & Biotechnology sector.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Surges 20% to Hit Upper Circuit Amid Robust Buying Pressure

2026-02-02 11:00:11

Biofil Chemicals & Pharmaceuticals Ltd witnessed a remarkable surge on 2 Feb 2026, hitting its upper circuit limit with a 19.99% gain to close at ₹42.13. The stock demonstrated strong buying momentum, outpacing its sector and broader market indices, driven by heightened investor interest and significant unfilled demand.

Read full news article

View All News